Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Death receptor 6 negatively regulates oligodendrocyte survival, maturation and myelination.
Disability weight for each level of the Expanded Disability Status Scale in multiple sclerosis.
Clinical trials in progressive multiple sclerosis: lessons learned and future perspectives.
Long-Term Results Underscore Value of Early MS Treatment
Patient Perspectives and Experience with Dalfampridine Treatment in Multiple Sclerosis-Related Walking Impairment: The Step Together Program.
Subcellular distribution of FTY720 and FTY720-phosphate in immune cells - another aspect of Fingolimod action relevant for therapeutic application.
The role of laquinimod in modulation of the immune response in relapsing-remitting multiple sclerosis: Lessons from gene expression signatures.
Submembranous cytoskeletons stabilize nodes of Ranvier.
Vitamin D: a natural inhibitor of multiple sclerosis.
In vitro screening of NADPH oxidase inhibitors and in vivo effects of L-leucinethiol on experimental autoimmune encephalomyelitis-induced mice.
An Inventory of Short Term and Long Term Changes in Gene Expression Under Interferon β Treatment of Relapsing Remitting MS Patients.
Gray matter is targeted in first-attack multiple sclerosis.
Sleep Disorders and Multiple Sclerosis: A Clinical and Polysomnography Study.
Impact of Fingolimod Therapy on Magnetic Resonance Imaging Outcomes in Patients With Multiple SclerosisImpact of Fingolimod Therapy in Multiple Sclerosis.
Current Immune Therapies of Autoimmune Disease of the Nervous System with Special Emphasis to Multiple Sclerosis.
Neuromyelitis Optica Following Human Papillomavirus Vaccination.
Genzyme to Resubmit LemtradaTM Application for FDA Review
Disease-modifying drugs for multiple sclerosis and JC virus expression.
Oligodendrocytes Enforce Immune Tolerance of the Uninfected Brain by Purging the Peripheral Repertoire of Autoreactive CD8(+) T Cells.
Separated at birth? The functional and molecular divergence of OLIG1 and OLIG2.
Organic solvents as risk factor for autoimmune diseases: a systematic review and meta-analysis.
Substance Name: Naltrexone
High levels of cerebrospinal fluid free kappa chains predict conversion to multiple sclerosis.
RORγt(+) cells selectively express redundant cation channels linked to the Golgi apparatus.
Changes in Cognitive Processing Speed, Mood, and Fatigue in an Observational Study of Persons With Multiple Sclerosis Treated With Dalfampridine-ER.

Pages